These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2995599)

  • 1. Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer.
    Pedersen AG; Bach FW; Nissen M; Bach F
    J Clin Oncol; 1985 Oct; 3(10):1364-72. PubMed ID: 2995599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer.
    Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer.
    Pedersen AG; Becker KL; Bach F; Snider RH; Gazdar AF; Sorensen PS; Bunn PA; Hansen HH
    J Clin Oncol; 1986 Nov; 4(11):1620-7. PubMed ID: 3021922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid vasopressin as a marker of central nervous system metastases from small-cell bronchogenic carcinoma.
    Pedersen AG; Hammer M; Hansen M; Sørensen PS
    J Clin Oncol; 1985 Jan; 3(1):48-53. PubMed ID: 2981291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
    Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
    Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid ACTH as a marker of central nervous system metastases from small cell carcinoma of the lung.
    Pedersen AG; Hansen M; Hummer L; Rogowski P
    Cancer; 1985 Nov; 56(10):2476-80. PubMed ID: 2994879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in patients with lung cancer.
    Hansen M; Pedersen AG
    Chest; 1986 Apr; 89(4 Suppl):219S-224S. PubMed ID: 3007040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate.
    Kärkelä J; Pasanen M; Kaukinen S; Mörsky P; Harmoinen A
    Crit Care Med; 1992 Mar; 20(3):378-86. PubMed ID: 1541099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
    Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
    Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum creatine kinase BB levels in patients with small cell lung cancer.
    Carney DN; Zweig MH; Ihde DC; Cohen MH; Makuch RW; Gazdar AF
    Cancer Res; 1984 Nov; 44(11):5399-403. PubMed ID: 6091876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of brain-type creatine kinase in serum from patients with carcinoma.
    Coolen RB; Pragay DA; Nosanchuk JS; Belding R
    Cancer; 1979 Oct; 44(4):1414-8. PubMed ID: 227564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke.
    Matias-Guiu J; Martinez-Vazquez J; Ruibal A; Colomer R; Boada M; Codina A
    Acta Neurol Scand; 1986 May; 73(5):461-5. PubMed ID: 2425541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung.
    Nikliński J; Furman M; Laudański J; Pałynyczko Z; Welk M
    Neoplasma; 1991; 38(2):129-35. PubMed ID: 1645850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
    Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
    Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid creatine kinase isoenzyme BB levels do not predict the clinical outcome in patients unconscious following cardiac resuscitation.
    Clemmensen P; Strandgaard S; Rasmussen S; Grande P
    Clin Cardiol; 1987 Apr; 10(4):235-6. PubMed ID: 3581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum CK-MB and CK-BB isoenzymes in a patient with small cell lung cancer: a case report.
    Wang HC; Lu JY; Ting YM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):270-3. PubMed ID: 7780887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage.
    Coplin WM; Longstreth WT; Lam AM; Chandler WL; Mayberg TS; Fine JS; Winn HR
    Arch Neurol; 1999 Nov; 56(11):1348-52. PubMed ID: 10555654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.